Q4 2023

Source filing unavailable

Q4 2023 · —

derived · Computed from the longer spans the company filed.

Revenue—

Net income—

EPS, diluted—Not derived. Share counts vary by quarter.

Operating Cash FlowderivedCA$248,003N/M

Free Cash Flowderived-CA$95,323N/M

Same quarter

Metric	Q4 2023derived from reported figures	Q4 2022derived from reported figures

The same fiscal quarter, prior years. Thaler holds no estimates to compare against.

Avricore Health Inc. · CIK 1355736 · Engraved from SEC EDGAR